• Clinical science

Disorders of sex development

Summary

Disorders of sex development are a group of congenital conditions that affect the development of the chromosomal, gonadal, or phenotypic sex. The underlying genetic mutations affect the number and function of sex chromosomes (e.g., in Turner syndrome), lead to structural changes with altered sensitivity of hormone receptors (e.g., androgen insensitivity syndrome), or alter the function of enzymes responsible for sex hormone synthesis (e.g., congenital adrenal hyperplasia). The most characteristic clinical feature is the development of a sexual phenotype which does not correspond to the sexual genotype. Other common features include reduced fertility or infertility and concomitant organ malformations (e.g., cardiac abnormalities). Disorders of sex development can also present with difficulties in gender identification and cause considerable psychological distress. The diagnosis of these conditions is based on characteristic clinical features, evaluation of hormone levels, and genetic testing. Management includes hormone substitution, possibly sex reassignment surgery, and psychological counseling.

Congenital adrenal hyperplasia

Androgen insensitivity syndrome

  • Etiology: X-linked recessive mutation of the gene locus encoding the androgen receptor → varying degrees of end-organ insensitivity to androgens
  • Karyotype: 46,XY
  • Clinical features
    • Complete androgen insensitivity
      • Female external genitalia (testicular feminization) and physique
      • Blind-ended vaginal pouch, uterine agenesis
      • Scant or missing pubic hair
      • Primary amenorrhea, infertility (no menarche)
    • Partial androgen insensitivity: variations in phenotype, depending on the degree of androgen insensitivity
    • Male internal genitalia
    • Detection of abdominal/inguinal masses in newbornsintra-abdominal localization of undescended testicles
  • Diagnostics
  • Therapy
    • Management depends on receptor status and, especially, on the phenotype and gender identity of the affected patient.
    • Hormone treatment
    • Gonadectomy for intra-abdominal testicles typically performed after puberty (high risk of malignancy)
    • Psychological support

References:[1]

Aromatase deficiency

  • Karyotype: 46 XX or 46 XY (normal sex development)
  • Pathophysiology: : Mutations in the CYP19A1 gene which encodes for the enzyme aromatase ↓ serum estrogen and ↑ serum testosterone
  • Clinical features
  • Treatment
    • Estrogen and progesterone replacement therapy
    • Calcium and vitamin D supplementation
    • Surgical correction of ambiguous genitalia

References:[2][3]

5-alpha-reductase deficiency

  • Synonym: pseudovaginal perineoscrotal hypospadias (PPSH)
  • Etiology: rare autosomal recessive loss-of-function mutation of chromosome 2
  • Karyotype: 46,XY
  • Pathophysiology
    • Normal testosterone production
    • Defective 5-alpha-reductase: testosterone not converted into dihydrotestosterone (DHT)DHT-dependent virilization of genitalia does not occur
  • Clinical features
    • Female external genitalia at birth, sometimes with pseudovaginal perineoscrotal hypospadias
    • Internal urogenital organs are male
    • In puberty, increasing synthesis of testosterone leads to virilization (phallic growth, testicular descent, development of male gender identity).
  • Diagnostics
  • Therapy
    • Female gender identity: gonadectomy; estrogen substitution therapy upon completion of longitudinal growth
    • Male gender identity: testosterone substitution

References:[4][5]

Klinefelter syndrome

  • Karyotype: 47 XXY, rarely 48 XXXY and 48 XXYY
  • Incidence: approximately 1:600 children
  • Etiology: most commonly due to nondisjunction of sex chromosomes during meiosis of parental germ cells
  • Clinical features
  • Diagnostics: : primarily a clinical diagnosis; karyotyping confirms the diagnosis
  • Complications: Increased risk of breast cancer development due to decreased levels of testosterone and increased levels of estrogen.
  • Therapy: life-long testosterone substitution

References:[6][7]

Turner syndrome

References:[6][8][9][10][11][12][13]

Ovotesticular disorder of sex development

Pure gonadal dysgenesis

References:[14]

Swyer syndrome

References:[15][16][17]

  • 1. Hiort O, Snyder PJ, Matsumoto AM, Geffner ME, Martin KA. Diagnosis and Treatment of Disorders of the Androgen Receptor. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/diagnosis-and-treatment-of-disorders-of-the-androgen-receptor. Last updated April 17, 2017. Accessed September 10, 2017.
  • 2. Le T, Bhushan V, Sochat M, Petersen M, Micevic G, Kallianos K. First Aid for the USMLE Step 1 2014. McGraw-Hill Medical; 2014.
  • 3. Carani C, Rochira V. Aromatase Deficiency. http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=GB&Expert=91. Updated April 1, 2013. Accessed September 10, 2017.
  • 4. Hiort O, Snyder PJ, Matsumoto AM, Martin KA. Steroid 5-Alpha-Reductase 2 Deficiency. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/steroid-5-alpha-reductase-2-deficiency. Last updated November 10, 2015. Accessed September 10, 2017.
  • 5. Isfort AH, Hoffman RP. 5-Alpha-Reductase Deficiency . In: 5-Alpha-Reductase Deficiency . New York, NY: WebMD. http://emedicine.medscape.com/article/924291. Updated November 11, 2016. Accessed September 10, 2017.
  • 6. Le T, Bhushan V, Bagga HS. First Aid for the USMLE Step 2 CK. McGraw-Hill Medical; 2009.
  • 7. Defendi GL, Rohena LO. Klinefelter Syndrome. In: Klinefelter Syndrome. New York, NY: WebMD. http://emedicine.medscape.com/article/945649. Updated April 20, 2017. Accessed September 10, 2017.
  • 8. Daniel MS, Rohena LO. Turner Syndrome. In: Turner Syndrome. New York, NY: WebMD. http://emedicine.medscape.com/article/949681. Updated June 17, 2016. Accessed February 19, 2017.
  • 9. Backeljauw P. Clinical Manifestations and Diagnosis of Turner Syndrome. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-turner-syndrome. Last updated May 23, 2018. Accessed May 28, 2018.
  • 10. De Groote K, Demulier L, De Backer J, et al. Arterial hypertension in Turner syndrome. J Hypertens. 2015: p. 1. doi: 10.1097/hjh.0000000000000599.
  • 11. Backeljauw P. Management of Turner Syndrome. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/management-of-turner-syndrome. Last updated December 13, 2017. Accessed May 28, 2018.
  • 12. Stochholm K, Juul S, Juel K, Naeraa RW, Højbjerg Gravholt C. Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. Send to J Clin Endocrinol Metab. 2006; 91(10): pp. 3897–3902. doi: 10.1210/jc.2006-0558.
  • 13. Elsheikh M, Dunger DB, Conway GS, Wass JAH. Turner’s syndrome in adulthood. Endocr Rev. 2002; 23(1): pp. 120–140. doi: 10.1210/edrv.23.1.0457.
  • 14. Pertusa S, Palacios A. 46 XX pure gonadal dysgenesis: an infrequent cause of primary amenorrhoea. BMJ Case Rep. 2009. doi: 10.1136/bcr.07.2008.0485.
  • 15. Baron J, Warenik-Szymankiewicz A, Miedzianowski J, Baron JJ. New aspects of diagnosing and treating pure gonadal dysgenesis 46XY and 46XX. Endokrynol Pol. 1993; 44(4): pp. 483–496. pmid: 8055817.
  • 16. Lifshitz F. Pediatric Endocrinology . New York, NY: Informa Healthcare USA, Inc.; 2007.
  • 17. King TFJ, Conway GS. Swyer syndrome. Send to Curr Opin Endocrinol Diabetes Obes. 2014; 21(6): pp. 504–510. doi: 10.1097/med.0000000000000113.
  • Catherine Dode, Jean-Pierre Hardelin. Kallmann Syndrome. European Journal of Human Genetics. 2008; 17(2): pp. 139–146. doi: 10.1038/ejhg.2008.206.
  • Genetics Home Reference. SOX9 Gene. https://ghr.nlm.nih.gov/gene/SOX9. Updated April 2, 2019. Accessed April 11, 2019.
  • ,Sheila Unger, Gerd Scherer, Andrea Superti-Furga. Campomelic dysplasia. GeneReviews. 2008.
  • Genetic and Rare Diseases Information Center. Persistent Mullerian Duct Syndrome. https://rarediseases.info.nih.gov/diseases/8435/persistent-mullerian-duct-syndrome. Accessed April 11, 2019.
  • Divya Renu, B Ganesh Rao, K Ranganath, Namitha. Persistent Mullerian Syndrome. Indian Journal of Radiology and Imaging. 2010; 20(1): pp. 72–74. doi: 10.4103/0971-3026.59761.
  • LI Smith-Harrison, Mehul S. Patel, Ryan P. Smith, Noah S. Schenkman. Persistent Mullerian duct structures presenting as hematuria in an adult: Case report of robotic surgical removal and review of the literature. Urology Annals. 2015; 7(4): pp. 544–546. doi: 10.4103/0974-7796.164859.
  • Tritos NA. Kallmann Syndrome and Idiopathic Hypogonadotropic Hypogonadism. In: Griffing GT. Kallmann Syndrome and Idiopathic Hypogonadotropic Hypogonadism. New York, NY: WebMD. https://emedicine.medscape.com/article/122824. Updated October 10, 2016. Accessed May 28, 2018.
  • National Organization for Rare Disorders. Kallmann syndrome. https://rarediseases.org/rare-diseases/kallmann-syndrome/. Updated January 1, 2012. Accessed April 5, 2019.
  • Ceci M, Calleja E, Said E, Gatt N. A case of true hermaphroditism presenting as a testicular tumour. Case Rep Urol. 2015; 2015: p. 598138. doi: 10.1155/2015/598138.
  • Dayal MB. Ovotesticular Disorder of Sexual Development. In: Scott Lucidi R. Ovotesticular Disorder of Sexual Development. New York, NY: WebMD. https://emedicine.medscape.com/article/256289. Updated January 12, 2017. Accessed November 17, 2018.
  • National Organization for Rare Disorders. XYY Syndrome. https://rarediseases.org/rare-diseases/xyy-syndrome/. Updated January 1, 2012. Accessed March 6, 2017.
  • Le T, Bhushan V,‎ Sochat M, Chavda Y, Zureick A. First Aid for the USMLE Step 1 2018. New York, NY: McGraw-Hill Medical; 2017.
  • Kim IW, Khadilkar AC, Ko EY, Sabanegh ES. 47,XYY syndrome and male infertility. Rev Urol. 2013; 15(4): pp. 188–196. url: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922324/.
  • Annemie LM Boehmer, Albert O Brinkmann, Lodewijk A. Sandkuijl, et al. 17β-Hydroxysteroid Dehydrogenase-3 Deficiency: Diagnosis, Phenotypic Variability, Population Genetics, and Worldwide Distribution of Ancient and de Novo Mutations. Journal of Clinical Endocrinology and Metabolism. 1999; 84(12): pp. 4713–4721. doi: 10.1210/jcem.84.12.6174.
last updated 04/11/2019
{{uncollapseSections(['ljcv0c0', 'AkcRqc0', '_kc5qc0', 'ELc8z10', 'zkcrqc0', 'sjctbc0', 'HjcKbc0', 'IxcYBe0', '7jc4bc0', 'rjcfbc0'])}}